Federico Nichetti

1.6k total citations · 1 hit paper
47 papers, 594 citations indexed

About

Federico Nichetti is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Federico Nichetti has authored 47 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 12 papers in Cancer Research. Recurrent topics in Federico Nichetti's work include Colorectal Cancer Treatments and Studies (8 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Federico Nichetti is often cited by papers focused on Colorectal Cancer Treatments and Studies (8 papers), Pancreatic and Hepatic Oncology Research (7 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (7 papers). Federico Nichetti collaborates with scholars based in Italy, Germany and United States. Federico Nichetti's co-authors include Filippo de Braud, Sara Pusceddu, Maria Di Bartolomeo, Francesca Corti, Monica Niger, Alessandra Raimondi, Natalie Prinzi, Martina Torchio, Claudio Vernieri and Marco Platania and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Scientific Reports.

In The Last Decade

Federico Nichetti

45 papers receiving 592 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer

2024 47 citations Federico Nichetti, Chiara Pircher et al. JAMA Network Open profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Federico Nichetti Italy	13	353	171	166	156	92	47	594
Han Jo Kim South Korea	16	265 0.8×	248 1.5×	149 0.9×	131 0.8×	76 0.8×	47	642
Olga Nigro Italy	11	340 1.0×	173 1.0×	168 1.0×	99 0.6×	57 0.6×	41	643
Xuan Hong China	15	394 1.1×	286 1.7×	164 1.0×	220 1.4×	77 0.8×	36	750
Xianghua Yi China	14	236 0.7×	206 1.2×	257 1.5×	91 0.6×	101 1.1×	64	700
Ran Hong South Korea	14	162 0.5×	202 1.2×	113 0.7×	64 0.4×	99 1.1×	56	600
Jian-Nong Zhou China	15	308 0.9×	283 1.7×	113 0.7×	147 0.9×	218 2.4×	28	797
Ying Tian China	16	236 0.7×	347 2.0×	112 0.7×	177 1.1×	100 1.1×	40	686
Benoîte Méry France	12	183 0.5×	149 0.9×	147 0.9×	80 0.5×	66 0.7×	68	552
Oktay Bozkurt Türkiye	13	248 0.7×	88 0.5×	113 0.7×	105 0.7×	59 0.6×	44	427
Koichi Saruwatari Japan	12	342 1.0×	333 1.9×	212 1.3×	110 0.7×	47 0.5×	38	694

Countries citing papers authored by Federico Nichetti

Since Specialization

Citations

This map shows the geographic impact of Federico Nichetti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Federico Nichetti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Federico Nichetti more than expected).

Fields of papers citing papers by Federico Nichetti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Federico Nichetti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Federico Nichetti. The network helps show where Federico Nichetti may publish in the future.

Co-authorship network of co-authors of Federico Nichetti

This figure shows the co-authorship network connecting the top 25 collaborators of Federico Nichetti. A scholar is included among the top collaborators of Federico Nichetti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Federico Nichetti. Federico Nichetti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pietrantonio, Filippo, Federica Morano, Monica Niger, et al.. (2024). The Prostaglandin EP4 Antagonist Vorbipiprant Combined with PD-1 Blockade for Refractory Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib/IIa Trial. Clinical Cancer Research. 31(4). 649–658. 2 indexed citations

Nichetti, Federico, Chiara Pircher, Michele Droz Dit Busset, et al.. (2024). NALIRIFOX, FOLFIRINOX, and Gemcitabine With Nab-Paclitaxel as First-Line Chemotherapy for Metastatic Pancreatic Cancer. JAMA Network Open. 7(1). e2350756–e2350756. 47 indexed citations breakdown →

Nichetti, Federico, Sara Lonardi, Filippo Pietrantonio, et al.. (2023). Comparative Genomic Analysis and Clinical Outcomes of BRAF -mutated Advanced Biliary Tract Cancers. Clinical Cancer Research. 29(23). 4853–4862. 8 indexed citations

Raimondi, Alessandra, Federico Nichetti, Arndt Stahler, et al.. (2023). Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials. European Journal of Cancer. 190. 112945–112945. 7 indexed citations

Silvestri, Marco, Trung Nghia Vu, Federico Nichetti, et al.. (2023). Comprehensive transcriptomic analysis to identify biological and clinical differences in cholangiocarcinoma. Cancer Medicine. 12(8). 10156–10168. 7 indexed citations

Pietrantonio, Filippo, Francesca Bergamo, Daniele Rossini, et al.. (2023). Negative hyperselection of elderly patients with RAS and BRAF wild-type metastatic colorectal cancer receiving initial panitumumab plus FOLFOX or 5-FU/LV. European Journal of Cancer. 195. 113396–113396. 8 indexed citations

Niger, Monica, Federico Nichetti, Sabina Murgioni, et al.. (2023). SO-3 Clinical relevance and actionability of BRAF alterations in advanced biliary tract cancer: Preliminary results from the multicenter B-REAL study. Annals of Oncology. 34. S162–S163. 1 indexed citations

Nichetti, Federico, et al.. (2020). 1702P COVID-19 risk for patients undergoing anticancer treatment at the outpatient clinic of the National Cancer Institute of Milan: The COVINT study. Annals of Oncology. 31. S1003–S1003. 1 indexed citations

Vernieri, Claudio, Alessandra Raimondi, Francesca Ligorio, et al.. (2020). 146P Safety and metabolic effects of fasting-mimicking diet in breast cancer patients. Annals of Oncology. 31. S68–S68. 1 indexed citations

10.

Nichetti, Federico, Antonio Marra, Carlo Alberto Giorgi, et al.. (2020). 337P Efficacy of everolimus plus exemestane in CDK 4/6 inhibitors-pretreated or naïve HR-positive/HER2-negative breast cancer patients: A secondary analysis of the EVERMET study. Annals of Oncology. 31. S382–S382. 5 indexed citations

11.

Moretto, Roberto, Federica Morano, Elena Ongaro, et al.. (2019). Lack of Benefit From Anti-EGFR Treatment in RAS and BRAF Wild-type Metastatic Colorectal Cancer With Mucinous Histology or Mucinous Component. Clinical Colorectal Cancer. 18(2). 116–124. 7 indexed citations

12.

Galli, Giulia, Stefano Cavalieri, Lorenza Di Guardo, et al.. (2019). Combination of Immunotherapy and Brain Radiotherapy in Metastatic Melanoma: A Retrospective Analysis. Oncology Research and Treatment. 42(4). 182–189. 19 indexed citations

13.

Nichetti, Federico, Felicia Stefania Falvella, Rosalba Miceli, et al.. (2019). Is a pharmacogenomic panel useful to estimate the risk of oxaliplatin-related neurotoxicity in colorectal cancer patients?. The Pharmacogenomics Journal. 19(5). 465–472. 16 indexed citations

14.

Corti, Francesca, Federico Nichetti, Alessandra Raimondi, et al.. (2018). Targeting the PI3K/AKT/mTOR pathway in biliary tract cancers: A review of current evidences and future perspectives. Cancer Treatment Reviews. 72. 45–55. 89 indexed citations

15.

Nichetti, Federico, Antonio Marra, Francesca Corti, et al.. (2018). The Role of Mesothelin as a Diagnostic and Therapeutic Target in Pancreatic Ductal Adenocarcinoma: A Comprehensive Review. Targeted Oncology. 13(3). 333–351. 16 indexed citations

16.

Prinzi, Natalie, Andrea Anichini, Roberta Mortarini, et al.. (2018). Treatment of Advanced Merkel Cell Carcinoma: Current Therapeutic Options and Novel Immunotherapy Approaches. Targeted Oncology. 13(5). 567–582. 9 indexed citations

17.

Cavalieri, Stefano, Federico Nichetti, Daniele Morelli, et al.. (2017). Pro-GRP in small cell lung cancer. Annals of Oncology. 28. ii18–ii18. 1 indexed citations

18.

Cremolini, Chiara, Filippo Pietrantonio, Gianluca Tomasello, et al.. (2017). Vinorelbine in BRAF V600E mutated metastatic colorectal cancer: a prospective multicentre phase II clinical study. ESMO Open. 2(3). e000241–e000241. 15 indexed citations

19.

Cavalieri, Stefano, Alessandra Raimondi, Daniele Morelli, et al.. (2016). Pro-gastrin releasing peptide (pro-GRP) in small cell lung cancer staging. Annals of Oncology. 27. iv13–iv13. 1 indexed citations

20.

Cremolini, Chiara, Carlotta Antoniotti, Filippo Pietrantonio, et al.. (2016). Surrogate Endpoints in Second-Line Trials of Targeted Agents in Metastatic Colorectal Cancer: A Literature-Based Systematic Review and Meta-Analysis. Cancer Research and Treatment. 49(3). 834–845. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact